Annual Report · 10-K
Aspira Women's Health Inc.
AWHLOTCEQUITYCurrent
Annual Report
Company context
We are dedicated to the discovery, development, and commercialization of noninvasive, AI-powered tests to aid in the diagnosis of gynecologic diseases, starting with ovarian cancer.
Current securities
Recent company filings
- 10-Q filingAug 14, 2026
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementJul 15, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJul 7, 2026
- D filingJun 22, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJun 22, 2026
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗